WEST PHARMACEUTICAL SERVICES INC (WST) Latest Filing Signal
Cross-checked across multiple AI analysts and grounded in the latest SEC filing.
powered by: earningsVibe.ai
Question:
What is the latest filing signal for WEST PHARMACEUTICAL SERVICES INC?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest
10-K, WEST PHARMACEUTICAL SERVICES INC's filing signal
turned positive.
earningsVibe SuperAnalyst™ Verdict:
TURNED POSITIVE
Signal Performance — Stock Price Since Filing
30-Day Change
-1.18%
from filing date
60-Day Change
Pending
from filing date
Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT
PERPLEXITY
Turned Positive
GEMINI
Turned Positive
CLAUDE
Turned Positive
CHATGPT
Turned Positive
Unlock the Full Filing Analysis
See full earningsSig™ and risksSig™ analysis across 5,000+ companies
Get Started Free →No credit card required
Question:
What does WEST PHARMACEUTICAL SERVICES INC actually do?
Answer:
West Pharmaceutical Services, Inc. is a global manufacturer specializing in integrated containment and delivery systems for injectable drugs and healthcare products. The company operates through two segments: Proprietary Products, offering packaging components, containment solutions, and drug delivery devices, and Contract-Manufactured Products, which focuses on complex device design, manufacturing, and assembly. West serves leading biologic, generic, pharmaceutical, diagnostic, and medical device companies worldwide. Its product portfolio includes stoppers, seals, syringe and cartridge components, and self-injection devices, complemented by analytical lab services and engineering support. With a strong emphasis on quality and innovation, West aims to enhance the safe and efficient delivery of medicines to patients.
Question:
What are WEST PHARMACEUTICAL SERVICES INC's revenue drivers?
Answer:
Revenue is driven by the sale of proprietary packaging, containment solutions, and drug delivery devices, as well as contract manufacturing and assembly services for complex medical devices. Key product lines include Westar(R), NovaChoice(R), and Envision(R) products, alongside self-injection devices for conditions like obesity and diabetes.
Cut through noisy SEC filings to find the signal faster
Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.
Get Started Free →No credit card required